These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 909444)

  • 1. Labeling of catechol-O-methyltransferase with N-haloacetyl derivatives.
    Borchardt RT; Thakker DR
    Methods Enzymol; 1977; 46():554-61. PubMed ID: 909444
    [No Abstract]   [Full Text] [Related]  

  • 2. Affinity labeling of catechol O-methyltransferase by N-haloacetyl derivatives of 3,5-dimethoxy-4-hydroxyphenylethylamine and 3,4-dimethoxy-5-hydroxyphenylethylamine. Kinetics of inactivation.
    Borchardt RT; Thakker DR
    Biochemistry; 1975 Oct; 14(20):4543-51. PubMed ID: 240407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 3,4-dimethoxyphenethylamine derivatives on monoamine oxidase.
    Keller WJ; Ferguson GG
    J Pharm Sci; 1977 Jul; 66(7):1048-50. PubMed ID: 886445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol O-methyltransferase. 6. Affinity labeling with N-haloacetyl-3,5-dimethoxy-4-hydroxyphenylalkylamines.
    Borchardt RT; Thakker DR
    J Med Chem; 1975 Feb; 18(2):152-8. PubMed ID: 1120981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic studies on catechol O-methyltransferase. Product inhibition and the nature of the catechol binding site.
    Coward JK; Slixz EP; Wu FY
    Biochemistry; 1973 Jun; 12(12):2291-7. PubMed ID: 4736330
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychomimetic compounds in the urine of schizophrenics. I. Study of catechol derivatives: so-called Pink Spot and 3.4-dimethoxyphenylethylamine (DMPEA)].
    Willmann PK; Bidziński A; Jakimow B; Puzyński S
    Psychiatr Pol; 1977; 11(2):143-9. PubMed ID: 887672
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychoactivity of normacromerine in animals.
    Bourn WM; Keller WJ; Bonfiglio JF
    Life Sci; 1978 Sep; 23(11):1175-84. PubMed ID: 713693
    [No Abstract]   [Full Text] [Related]  

  • 8. Catechol O-methyltransferase. 12. Affinity labeling the active site with the oxidation products of 5,6-dihydroxyindole.
    Borchardt RT; Bhatia P
    J Med Chem; 1982 Mar; 25(3):263-71. PubMed ID: 7069705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol O-methyltransferase. 5. Structure-activity relationships for inhibition by flavonoids.
    Borchardt RT; Huber JA
    J Med Chem; 1975 Jan; 18(1):120-2. PubMed ID: 1109569
    [No Abstract]   [Full Text] [Related]  

  • 10. Haloacetyl derivatives.
    Wilchek M; Givol D
    Methods Enzymol; 1977; 46():153-7. PubMed ID: 909404
    [No Abstract]   [Full Text] [Related]  

  • 11. Facilitation and disruption by mescaline and 3,4-dimethoxyphenylethylamine of shock avoidance in rats.
    Gorelick DA; Bridger WH
    Psychopharmacology (Berl); 1977 Apr; 52(2):157-63. PubMed ID: 407599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and inhibition studies on catechol-O-methyltransferase affinity labelling by N-(3,4-dihydroxyphenyl)maleimide.
    Piedrafita FJ; Fernandez-Alvarez E; Nieto O; Tipton KF
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):951-8. PubMed ID: 1417755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 14. Catechol O-methyltransferase. 8. Structure-activity relationships for inhibtion by 8-hydroxyquinolines.
    Borchardt RT; Thakker DR; Warner VD; Mirth DB; Sane JN
    J Med Chem; 1976 Apr; 19(4):558-60. PubMed ID: 817025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes.
    Villalobos CA; Bull P; Sáez P; Cassels BK; Huidobro-Toro JP
    Br J Pharmacol; 2004 Apr; 141(7):1167-74. PubMed ID: 15006903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of beta-(3,4-dimethoxyphenyl)ethyl amine: lack of peripheral and central antidopaminergic properties.
    Jarboe CH; Bannon MJ; Lipson SF
    J Pharm Pharmacol; 1978 Jul; 30(7):450-1. PubMed ID: 27614
    [No Abstract]   [Full Text] [Related]  

  • 17. Affinity labeling of catechol-O-methyltransferase with N-iodoacetyl-3,5-dimethoxy-4-hydroxyphenylethylamine.
    Borchardt RT; Thakker D
    Biochem Biophys Res Commun; 1973 Oct; 54(3):1233-9. PubMed ID: 4753192
    [No Abstract]   [Full Text] [Related]  

  • 18. Affinity labeling with omega-bromoacetamido fatty acids and analogs.
    Plapp BV; Chen WS
    Methods Enzymol; 1981; 72():587-91. PubMed ID: 7031428
    [No Abstract]   [Full Text] [Related]  

  • 19. Catechol O-methyltransferase. 2. In vitro inhibition by substituted 8-hydroxyquinolines.
    Borchardt RT
    J Med Chem; 1973 Apr; 16(4):382-7. PubMed ID: 4736750
    [No Abstract]   [Full Text] [Related]  

  • 20. Haloketones as affinity labeling reagents.
    Hartman FC
    Methods Enzymol; 1977; 46():130-53. PubMed ID: 909402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.